{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:33:00Z","timestamp":1787502780427,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Our aim was to compare survival of the various treatment modality groups of chemotherapy and\/or radiotherapy in relation to SEMS (self-expanding metal stents) in a retrospective case-control study. We have made the hypothesis that the administration of combined chemoradiotherapy improves survival in inoperable esophageal cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All patients were confirmed histologically as having surgically non- resectable esophageal carcinoma. Included were patients with squamous cell carcinoma, undifferentiated carcinoma as well as Siewert type I--but not type II - esophagogastric junctional adenocarcinoma. The decision to proceed with palliative treatments was taken within the context of a multidisciplinary team meeting and full expert review based on patient's wish, co-morbid disease, clinical metastases, distant metastases, M1 nodal metastases, T4-tumor airway, aorta, main stem bronchi, cardiac invasion, and peritoneal disease. Patients not fit enough to tolerate a radical course of definitive chemo- and\/or radiation therapy were referred for self-expanding metal stent insertion. Our approach to deal with potential confounders was to match subjects according to their clinical characteristics (contraindications for surgery) and tumor stage according to diagnostic work-up in four groups: SEMS group (A), Chemotherapy group (B), Radiotherapy group (C), and Chemoradiotherapy group (D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Esophagectomy was contraindicated in 155 (35.5%) out of 437 patients presenting with esophageal cancer to the Department of General and Abdominal Surgery of the University Hospital of Mainz, Germany, between November 1997 and November 2007. There were 133 males and 22 females with a median age of 64.3 (43-88) years. Out of 155 patients, 123 were assigned to four groups: SEMS group (A) n = 26, Chemotherapy group (B) n = 12, Radiotherapy group (C) n = 23 and Chemoradiotherapy group (D) n = 62. Mean patient survival for the 4 groups was as follows: Group A: 6.92 \u00b1 8.4 months; Group B: 7.75 \u00b1 6.6 months; Group C: 8.56 \u00b1 9.5 months, and Group D: 13.53 \u00b1 14.7 months. Significant differences in overall survival were associated with tumor histology (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.027), tumor localization (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.019), and type of therapy (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.005), respectively, in univariate analysis. Treatment modality (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.043) was the only independent predictor of survival in multivariate analysis. The difference in overall survival between Group A and Group D was highly significant (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01) and in favor of Group D. As concerns Group D versus Group B and Group D versus Group C there was a trend towards a difference in overall survival in favor of Group D (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.069 and\n                      <jats:italic>P<\/jats:italic>\n                      = 0.059, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The prognosis of inoperable esophageal cancer seems to be highly dependent on the suitability of the induction of patient-specific therapeutic measures and is significantly better, when chemoradiotherapy is applied.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1471-2407-12-70","type":"journal-article","created":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T16:14:22Z","timestamp":1329322462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Survival after chemotherapy and\/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study"],"prefix":"10.1186","volume":"12","author":[{"given":"George","family":"Sgourakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Gockel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine","family":"Karaliotas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Moehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Christoph","family":"Schimanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Schmidberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodor","family":"Junginger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,15]]},"reference":[{"key":"3076_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1442-2050.2004.00371.x","volume":"17","author":"GN Tytgat","year":"2004","unstructured":"Tytgat GN, Bartelink H, Bernards R, et al: Cancer of the esophagus and gastric cardia: recent advances. Dis Esophagus. 2004, 17: 10-26. 10.1111\/j.1442-2050.2004.00371.x.","journal-title":"Dis Esophagus"},{"key":"3076_CR2","first-page":"2800","volume":"149","author":"MY Homs","year":"2005","unstructured":"Homs MY, Steyerberg EW, Eijkenboom WM, et al: Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study. Ned Tijdschr Geneeskd. 2005, 149: 2800-2806.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"3076_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta9050","volume":"9","author":"J Shenfine","year":"2005","unstructured":"Shenfine J, McNamee P, Steen N, et al: A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. Health Technol Assess. 2005, 9: 1-121.","journal-title":"Health Technol Assess"},{"key":"3076_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1442-2050.2005.00467.x","volume":"18","author":"H Bergquist","year":"2005","unstructured":"Bergquist H, Wenger U, Johnsson E, et al: Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus. 2005, 18: 131-139. 10.1111\/j.1442-2050.2005.00467.x.","journal-title":"Dis Esophagus"},{"key":"3076_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1067\/mge.2001.118947","volume":"54","author":"HJ Dallal","year":"2001","unstructured":"Dallal HJ, Smith GD, Grieve DC, et al: A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc. 2001, 54: 549-557. 10.1067\/mge.2001.118947.","journal-title":"Gastrointest Endosc"},{"key":"3076_CR6","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1007\/s10620-010-1250-1","volume":"55","author":"G Sgourakis","year":"2010","unstructured":"Sgourakis G, Gockel I, Radtke A, et al: The use of self-expanding stents in esophageal and gastroesophageal junction cancer palliation: a meta-analysis and meta-regression analysis of outcomes. Dig Dis Sci. 2010, 55: 3018-3030. 10.1007\/s10620-010-1250-1.","journal-title":"Dig Dis Sci"},{"key":"3076_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00268-005-7861-6","volume":"30","author":"I Gockel","year":"2006","unstructured":"Gockel I, Kneist W, Junginger T: Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences. World J Surg. 2006, 30: 183-190. 10.1007\/s00268-005-7861-6.","journal-title":"World J Surg"},{"key":"3076_CR8","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1001\/archsurg.139.10.1043","volume":"139","author":"W Kneist","year":"2004","unstructured":"Kneist W, Schreckenberger M, Bartenstein P, et al: Prospective evaluation of positron emission tomography in the preoperative staging of esophageal carcinoma. Arch Surg. 2004, 139: 1043-1049. 10.1001\/archsurg.139.10.1043.","journal-title":"Arch Surg"},{"key":"3076_CR9","first-page":"25","volume":"58","author":"JR Siewert","year":"1987","unstructured":"Siewert JR, Holscher AH, Becker K, Gossner W: Cardia cancer: attempt at a therapeutically relevant classification. Chirurg. 1987, 58: 25-32.","journal-title":"Chirurg"},{"key":"3076_CR10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","volume":"326","author":"A Herskovic","year":"1992","unstructured":"Herskovic A, Martz K, Al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992, 326: 1593-1598. 10.1056\/NEJM199206113262403.","journal-title":"N Engl J Med"},{"key":"3076_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/1097-0142(19950715)76:2<178::AID-CNCR2820760204>3.0.CO;2-D","volume":"76","author":"AH Holscher","year":"1995","unstructured":"Holscher AH, Bollschweiler E, Schneider PM, Siewert JR: Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer. 1995, 76: 178-186. 10.1002\/1097-0142(19950715)76:2<178::AID-CNCR2820760204>3.0.CO;2-D.","journal-title":"Cancer"},{"key":"3076_CR12","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","volume":"281","author":"JS Cooper","year":"1999","unstructured":"Cooper JS, Guo MD, Herskovic A, et al: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999, 281: 1623-1627. 10.1001\/jama.281.17.1623.","journal-title":"JAMA"},{"key":"3076_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/00000421-199810000-00008","volume":"21","author":"CF Slabber","year":"1998","unstructured":"Slabber CF, Nel JS, Schoeman L, et al: A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol. 1998, 21: 462-465. 10.1097\/00000421-199810000-00008.","journal-title":"Am J Clin Oncol"},{"key":"3076_CR14","first-page":"CD002092","volume":"1","author":"R Wong","year":"2006","unstructured":"Wong R, Malthaner R: Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev. 2006, 1: CD002092-","journal-title":"Cochrane Database Syst Rev"},{"key":"3076_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/annonc\/mdf063","volume":"13","author":"T Conroy","year":"2002","unstructured":"Conroy T, Etienne PL, Adenis A, et al: Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival. European organisation for research and treatment of cancer gastrointestinal tract cancer cooperative group. Ann Oncol. 2002, 13: 721-729. 10.1093\/annonc\/mdf063.","journal-title":"Ann Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-70.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-70\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-70","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-70.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T16:54:41Z","timestamp":1630601681000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-70"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,15]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3076"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-70","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,15]]},"assertion":[{"value":"10 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"70"}}